相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer
Philip D. Poorvu et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4)
S. Paluch-Shimon et al.
ANNALS OF ONCOLOGY (2020)
Breast cancer-specific mortality (BCSM) in patients age 50 years or younger with node-positive (N plus ) breast cancer (BC) treated based on the 21-gene assay in clinical practice
Valentina I. Petkov et al.
CANCER RESEARCH (2020)
Should age be integrated together with clinical and genomic risk for adjuvant chemotherapy decision in early luminal breast cancer? MINDACT results compared to those of TAILOR-X
Martine J. Piccart et al.
CANCER RESEARCH (2020)
Characterization of oncotype DX recurrence score and chemotherapy utilization patterns in young women (≤40) with early stage ER plus /HER-, lymph node negative breast cancer
Sarah Sammons et al.
CANCER RESEARCH (2020)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up (vol 30, pg 128, 2019)
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx
Fabrice Andre et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Locally advanced breast cancer in young women in Latin America
Cynthia Villarreal-Garza et al.
ECANCERMEDICALSCIENCE (2019)
Change in therapeutic management after EndoPredict assay in a prospective decision impact study of Mexican premenopausal patients
C. Villarreal-Garza et al.
CANCER RESEARCH (2019)
Is Age Trumping Genetic Profiling in Clinical Practice? Relationship of Chemotherapy Recommendation and Oncotype DX Recurrence Score in Patients Aged < 50 Years versus ≥ 50 Years, and Trends Over Time
Austin D. Williams et al.
ANNALS OF SURGICAL ONCOLOGY (2018)
Abstract P1-06-06: No age-related outcome disparities according to 21-gene recurrence score groups in early breast cancer patients treated by adjuvant chemotherapy in the prospective WSG PlanB trial
N Harbeck et al.
CANCER RESEARCH (2018)
Abstract P1-07-08: Young age and the risk of disease recurrence as assessed by the 70-gene signature – an analysis from the EORTC 10041/BIG 03-04 MINDACT trial
K Aalders et al.
CANCER RESEARCH (2018)
Tumor PIK3CA Genotype and Prognosis in Early-Stage Breast Cancer: A Pooled Analysis of Individual Patient Data
Dimitrios Zardavas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant Chemotherapy Guided by a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Estimating the incidence of breast cancer in Africa: a systematic review and meta-analysis
Davies Adeloye et al.
JOURNAL OF GLOBAL HEALTH (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Selection for Oncotype Dx testing among young women with early-stage ER+/HER2-breast cancer.
Philip Daniel Poorvu et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
211POncotype Dx results in patients ≤40 years: Does age matter? New insights
F Namuche et al.
ANNALS OF ONCOLOGY (2018)
Should age impact breast cancer management in young women? Fine tuning of treatment guidelines
Matteo B. Suter et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
GATA3 frameshift mutation promotes tumor growth in human luminal breast cancer cells and induces transcriptional changes seen in primary GATA3 mutant breast cancers
John P. Gustin et al.
ONCOTARGET (2017)
Outcomes in Patients With Early-Stage Breast Cancer Who Underwent a 21-Gene Expression Assay
Carlos H. Barcenas et al.
CANCER (2017)
Breast Cancer Statistics, 2015: Convergence of Incidence Rates Between Black and White Women
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2016)
Prognostic Impact of the Combination of Recurrence Score and Quantitative Estrogen Receptor Expression (ESR1) on Predicting Late Distant Recurrence Risk in Estrogen Receptor-Positive Breast Cancer After 5 Years of Tamoxifen: Results From NRG Oncology/National Surgical Adjuvant Breast and Bowel Project B-28 and B-14
Norman Wolmark et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Subtype-Dependent Relationship Between Young Age at Diagnosis and Breast Cancer Survival
Ann H. Partridge et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Effect of Age on Breast Cancer Patient Prognoses: A Population-Based Study Using the SEER 18 Database
Hai-long Chen et al.
PLOS ONE (2016)
Quantitative Gene Expression by Recurrence Score in ER-Positive Breast Cancer, by Age
Sandra M. Swain et al.
ADVANCES IN THERAPY (2015)
Menopausal status does not predict Oncotype DX recurrence score
Danielle N. Carr et al.
JOURNAL OF SURGICAL RESEARCH (2015)
Adjuvant Ovarian Suppression in Premenopausal Breast Cancer
Prudence A. Francis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Prospective Validation of a 21-Gene Expression Assay in Breast Cancer
J. A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
First international consensus guidelines for breast cancer in young women (BCY1)
Ann H. Partridge et al.
BREAST (2014)
Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
Olivia Pagani et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2-breast cancer patients: results from the GEICAM 9906 trial
Miguel Martin et al.
BREAST CANCER RESEARCH (2014)
Biology of breast cancer in young women
Hatem A. Azim et al.
BREAST CANCER RESEARCH (2014)
GATA3 acts upstream of FOXA1 in mediating ESR1 binding by shaping enhancer accessibility
Vasiliki Theodorou et al.
GENOME RESEARCH (2013)
Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer
L. C. Collins et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study
Lawrence J. Solin et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Tumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
D. H. Morrison et al.
BRITISH JOURNAL OF CANCER (2012)
The European Society of Breast Cancer Specialists recommendations for the management of young women with breast cancer
Fatima Cardoso et al.
EUROPEAN JOURNAL OF CANCER (2012)
Breast Carcinomas Arising at a Young Age: Unique Biology or a Surrogate for Aggressive Intrinsic Subtypes?
Carey K. Anders et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Elevated Breast Cancer Mortality in Women Younger than Age 40 Years Compared with Older Women Is Attributed to Poorer Survival in Early-Stage Disease
Jennifer L. Gnerlich et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2009)
Breast Cancer in Young Women: Poor Survival Despite Intensive Treatment
Hanna Fredholm et al.
PLOS ONE (2009)
分享论文
